“We’ve already made, actually, billions of doses preparing for the launch,” Chief Executive Officer
Lilly hasn’t yet submitted the pill, called orforglipron, to US regulators but expects to do so before the end of the year. ...
“We’ve already made, actually, billions of doses preparing for the launch,” Chief Executive Officer
Lilly hasn’t yet submitted the pill, called orforglipron, to US regulators but expects to do so before the end of the year. ...